Cardiovascular Innovations Foundation (EIN 813064105) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

Subhash Banerjee

Tax Period

2023-01-01 to 2023-12-31

Cardiovascular Innovations Foundation, founded in 2016, is a community nonprofit in the Health Care sector that reported $1.5M in total revenue in fiscal year 2023. Expenses of $1.8M exceeded revenue, resulting in a 19% operating deficit.

Mission

Addressing unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of healthcare providers and the larger public.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $444,367

Program Service Revenue $0

Investment Income $0

Other Revenue $1,066,582

TOTAL REVENUE $1,510,949

Expense Breakdown

Grants Paid $0

Salaries & Benefits $174,970

Fundraising Expenses $23,431

Program Expenses $1,655,210

Other Expenses $1,619,096

TOTAL EXPENSES $1,794,066

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,510,949	$1,533,761	0.0%
Expenses	$1,794,066	$1,564,058	+0.1%
Net Income	$-283,117	$-30,297	+8.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Subhash Banerjee	Director	5.00	Director	$0	$0	$0
Emmanouil S Brilakis	Director	5.00	Director	$0	$0	$0
Mehdi H Shishehbor	Director	5.00	Director	$0	$0	$0
Paul Sorajja	Director	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,510,949	$1,794,066	$681,388	$-283,117
2022	$1,533,761	$1,564,058	$945,464	$-30,297
2021	$988,545	$526,864	$1,003,224	$461,681
2020	$715,304	$378,340	$557,175	$336,964
2019	$2,137,065	$2,141,686	$154,271	$-4,621
2018	$1,894,297	$1,822,250	$209,595	$72,047

Cardiovascular Innovations Foundation